Fischer G, Lindner S, Litau S, Schirrmacher R, Wängler B, Wängler C
§Department of Nuclear Medicine, University Hospital Munich, Ludwig Maximilians-University Munich, 81377 Munich, Germany.
∥Department of Oncology, Division Oncological Imaging, University of Alberta, Edmonton, Alberta T6G 1Z2, Canada.
Bioconjug Chem. 2015 Aug 19;26(8):1479-83. doi: 10.1021/acs.bioconjchem.5b00362. Epub 2015 Jul 24.
As the gastrin releasing peptide receptor (GRPR) is overexpressed on several tumor types, it represents a promising target for the specific in vivo imaging of these tumors using positron emission tomography (PET). We were able to show that PESIN-based peptide multimers can result in substantially higher GRPR avidities, highly advantageous in vivo pharmacokinetics and tumor imaging properties compared to the respective monomers. However, the minimal distance between the peptidic binders, resulting in the lowest possible system entropy while enabling a concomitant GRPR binding and thus optimized receptor avidities, has not been determined so far. Thus, we aimed here to identify the minimal distance between two GRPR-binding peptides in order to provide the basis for the development of highly avid GRPR-specific PET imaging agents. We therefore synthesized dimers of the GRPR-binding bombesin analogue BBN(7-14) on a dendritic scaffold, exhibiting different distances between both peptide binders. The homodimers were further modified with the chelator NODAGA, radiolabeled with (68)Ga, and evaluated in vitro regarding their GRPR avidity. We found that the most potent of the newly developed radioligands exhibits GRPR avidity twice as high as the most potent reference compound known so far, and that a minimal distance of 62 bond lengths between both peptidic binders within the homodimer can result in concomitant peptide binding and optimal GRPR avidities. These findings answer the question as to what molecular design should be chosen when aiming at the development of highly avid homobivalent peptidic ligands addressing the GRPR.
由于胃泌素释放肽受体(GRPR)在多种肿瘤类型中过表达,它是使用正电子发射断层扫描(PET)对这些肿瘤进行特异性体内成像的一个有前景的靶点。我们能够证明,基于PESIN的肽多聚体与各自的单体相比,可导致显著更高的GRPR亲和力、高度有利的体内药代动力学和肿瘤成像特性。然而,肽结合剂之间的最小距离,在实现GRPR结合从而优化受体亲和力的同时能使系统熵尽可能低,到目前为止尚未确定。因此,我们在此旨在确定两种GRPR结合肽之间的最小距离,以便为开发高亲和力的GRPR特异性PET成像剂提供基础。因此,我们在树枝状支架上合成了GRPR结合的蛙皮素类似物BBN(7 - 14)的二聚体,两个肽结合剂之间呈现不同距离。将同型二聚体进一步用螯合剂NODAGA修饰,用(68)Ga进行放射性标记,并在体外评估其GRPR亲和力。我们发现,新开发的放射性配体中最有效的一种表现出的GRPR亲和力是迄今已知最有效的参考化合物的两倍,并且同型二聚体内两个肽结合剂之间最小距离为62个键长可导致肽的同时结合和最佳GRPR亲和力。这些发现回答了在旨在开发针对GRPR的高亲和力同型二价肽配体时应选择何种分子设计的问题。